THOUSAND OAKS, Calif.–(BUSINESS WIRE)—- $ATRA #CART–Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced updated effectiveness and safety data for tabelecleucel (tab-cel® or EBVALLO™) from the multicenter…
News Ticker
- [ September 26, 2023 ] Muscle Lab Ignites a Wellness Evolution with the Launch of GPT-4 Driven Custom Recovery Plans and Smart Lab Los Angeles Biotech News
- [ September 26, 2023 ] Herbalife Steps Up to Support Healthy Active Lifestyles for 10th Consecutive Year as Nutrition Partner for Downtown Los Angeles YMCA’s Stair Climb & Urban Hike Los Angeles Biotech News
- [ September 26, 2023 ] CLININICAL LAB SCIENTIST I – PD – IRVINE HEMATOLOGY – Hoag Memorial Hospital Presbyterian – Irvine, CA Los Angeles Biotech Jobs
- [ September 26, 2023 ] How TikTok’s algorithm and audiences are finally convincing Big Pharma to join Los Angeles Biotech News
- [ September 26, 2023 ] Bristol Myers joins AstraZeneca in agreeing to drug price negotiation terms ahead of first deadline Los Angeles Biotech News
Copyright © 2023 Biotech Networks, LLC
